Financial results - STADA HEMOFARM SRL

Financial Summary - Stada Hemofarm Srl
Unique identification code: 2803570
Registration number: J35/1325/1992
Nace: 7120
Sales - Ron
17.056.159
Net Profit - Ron
411.869
Employees
Open Account
Company Stada Hemofarm Srl with Fiscal Code 2803570 recorded a turnover of 2024 of 17.056.159, with a net profit of 411.869 and having an average number of employees of - . The company operates in the field of Activităţi de testări şi analize tehnice having the NACE code 7120.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Stada Hemofarm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 3.790.678 4.231.462 4.714.554 5.798.866 6.390.443 7.253.162 7.217.318 11.807.430 17.551.782 17.056.159
Total Income - EUR 3.858.680 4.282.272 4.922.435 5.817.846 6.451.981 7.289.807 7.238.057 11.889.660 17.655.833 17.138.435
Total Expenses - EUR 3.655.182 4.150.281 4.679.357 5.563.733 6.284.073 6.977.441 7.223.200 11.694.059 17.939.115 16.662.811
Gross Profit/Loss - EUR 203.498 131.990 243.078 254.113 167.908 312.366 14.857 195.600 -283.283 475.624
Net Profit/Loss - EUR 165.919 101.551 194.025 207.829 139.060 250.441 -8.904 108.416 -321.976 411.869
Employees 55 68 75 90 105 121 0 148 180 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -2.3%, from 17.551.782 euro in the year 2023, to 17.056.159 euro in 2024. The Net Profit increased by 411.869 euro, from 0 euro in 2023, to 411.869 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Stada Hemofarm Srl

Rating financiar

Financial Rating -
STADA HEMOFARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Stada Hemofarm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Stada Hemofarm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Stada Hemofarm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Stada Hemofarm Srl - CUI 2803570

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 3.897.281 3.520.515 3.163.240 2.846.103 2.714.494 3.103.417 3.059.822 3.451.291 5.919.897 6.507.643
Current Assets 530.200 654.898 1.076.558 1.448.820 2.160.458 2.281.080 2.614.783 3.870.340 4.965.401 2.382.164
Inventories 98.802 133.609 190.423 221.366 218.085 343.296 441.296 540.016 583.192 524.618
Receivables 272.000 248.460 524.053 997.573 1.679.161 1.459.215 1.955.623 3.204.001 4.141.164 1.550.057
Cash 159.399 272.830 362.082 229.881 263.212 478.569 217.864 126.323 241.045 307.489
Shareholders Funds 3.340.000 3.407.488 3.543.852 3.686.646 3.754.309 3.933.577 3.837.443 3.941.685 3.607.756 3.999.463
Social Capital 2.610.009 2.583.390 2.539.675 2.493.068 2.444.787 2.398.439 2.345.251 2.352.528 2.345.394 2.332.286
Debts 1.223.315 776.260 963.518 928.236 1.134.469 1.439.253 1.817.121 3.337.138 7.042.038 6.361.881
Income in Advance 0 0 0 0 0 0 0 982.499 168.134 147.675
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7120 - 7120"
CAEN Financial Year 7120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.382.164 euro in 2024 which includes Inventories of 524.618 euro, Receivables of 1.550.057 euro and cash availability of 307.489 euro.
The company's Equity was valued at 3.999.463 euro, while total Liabilities amounted to 6.361.881 euro. Equity increased by 411.869 euro, from 3.607.756 euro in 2023, to 3.999.463 in 2024. The Debt Ratio was 60.5% in the year 2024.

Risk Reports Prices

Reviews - Stada Hemofarm Srl

Comments - Stada Hemofarm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.